Detalhe da pesquisa
1.
Factor XIII levels, clot strength, and impact of fibrinogen concentrate in infants undergoing cardiopulmonary bypass: a mechanistic sub-study of the FIBCON trial.
Br J Anaesth
; 130(2): 175-182, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371257
2.
Antifibrinolytic Drugs for the Prevention of Bleeding in Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Systematic Review and Meta-analysis.
Anesth Analg
; 134(5): 987-1001, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633994
3.
Strategies for Prevention and Management of Bleeding Following Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Scoping Review.
Pediatr Crit Care Med
; 19(1): 40-47, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29189637
4.
Developing integrated care pathways for atopic dermatitis-Challenges and unmet needs.
Clin Transl Allergy
; 13(3): e12236, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36973955
5.
Individualized, Intraoperative Dosing of Fibrinogen Concentrate for the Prevention of Bleeding in Neonatal and Infant Cardiac Surgery Using Cardiopulmonary Bypass (FIBCON): A Phase 1b/2a Randomized Controlled Trial.
Circ Cardiovasc Interv
; 13(12): e009465, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213194